HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidenori Arai Selected Research

Collagen

10/2016Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy.
6/2007SRY-related HMG box 9 regulates the expression of Col4a2 through transactivating its enhancer element in mesangial cells.
6/2005Role of insulin-like growth factor-I in allergen-induced airway inflammation and remodeling.
5/2004Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidenori Arai Research Topics

Disease

22Frailty
04/2024 - 11/2013
16Sarcopenia
11/2023 - 02/2014
15Diabetic Nephropathies (Diabetic Nephropathy)
08/2015 - 04/2004
14Dyslipidemias (Dyslipidemia)
04/2024 - 01/2012
12Atherosclerosis
09/2018 - 09/2004
11Coronary Artery Disease (Coronary Atherosclerosis)
01/2024 - 10/2010
11Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2023 - 12/2008
9Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 06/2009
9Dementia (Dementias)
01/2024 - 01/2012
8Hypertriglyceridemia
04/2024 - 06/2008
8Inflammation (Inflammations)
10/2022 - 06/2005
8Xanthomatosis (Xanthoma)
06/2022 - 01/2012
7Body Weight (Weight, Body)
01/2023 - 12/2008
7Drug-Related Side Effects and Adverse Reactions
01/2023 - 05/2004
7Insulin Resistance
11/2018 - 12/2008
7Glomerulonephritis
01/2016 - 02/2005
6Neoplasms (Cancer)
01/2023 - 05/2010
6COVID-19
01/2023 - 12/2020
6Albuminuria
10/2016 - 05/2003
5Hypertension (High Blood Pressure)
05/2022 - 01/2013
5Stroke (Strokes)
12/2021 - 10/2012
5Acute Coronary Syndrome
12/2021 - 10/2010
5Type 2 Diabetes Mellitus (MODY)
01/2019 - 12/2008
5Obesity
01/2016 - 06/2008
5Hypertrophy
01/2012 - 05/2003
5Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2010 - 01/2005
4Hypercholesterolemia
01/2024 - 11/2007
4Cognitive Dysfunction
01/2024 - 12/2021
4Weight Loss (Weight Reduction)
10/2023 - 07/2017
4Inborn Genetic Diseases (Disease, Hereditary)
05/2022 - 12/2008
4Diabetes Mellitus
10/2021 - 05/2004
4Coronary Disease (Coronary Heart Disease)
02/2021 - 01/2016
3Alzheimer Disease (Alzheimer's Disease)
01/2024 - 12/2021
3Cachexia
10/2023 - 01/2021
3Rheumatoid Arthritis
04/2023 - 06/2019
3Peripheral Nervous System Diseases (PNS Diseases)
10/2021 - 01/2018
3Malnutrition (Nutritional Deficiencies)
08/2021 - 02/2014
3Hyperglycemia
01/2011 - 04/2004
2Chronic Disease (Chronic Diseases)
10/2023 - 06/2022
2Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2021
2Stomach Neoplasms (Stomach Cancer)
01/2023 - 01/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 01/2021
2Muscle Weakness
01/2022 - 01/2017
2Chronic Obstructive Pulmonary Disease (COPD)
03/2021 - 01/2021
2Pulmonary Arterial Hypertension
06/2019 - 06/2019
2Deglutition Disorders (Dysphagia)
02/2019 - 10/2012
2Hyperlipidemias (Hyperlipidemia)
09/2018 - 01/2016
2Heart Diseases (Heart Disease)
05/2018 - 01/2016
2Breast Neoplasms (Breast Cancer)
01/2018 - 01/2016
2Death (Near-Death Experience)
06/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

25LipidsIBA
01/2024 - 03/2010
17oxidized low density lipoproteinIBA
06/2022 - 07/2007
15LDL CholesterolIBA
01/2024 - 08/2006
11Triglycerides (Triacylglycerol)IBA
04/2024 - 09/2004
11(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
04/2024 - 01/2018
10Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2019 - 11/2011
8Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2004
8Glucose (Dextrose)FDA LinkGeneric
01/2021 - 08/2006
7HDL CholesterolIBA
04/2024 - 08/2006
7CholesterolIBA
01/2024 - 09/2004
7LDL Lipoproteins (beta Lipoproteins)IBA
06/2022 - 07/2007
6Biomarkers (Surrogate Marker)IBA
10/2023 - 11/2008
6Insulin (Novolin)FDA Link
01/2021 - 05/2004
5Indicators and Reagents (Reagents)IBA
01/2024 - 01/2015
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2024 - 01/2018
4Ezetimibe (Zetia)FDA Link
01/2024 - 01/2012
4Probucol (Lorelco)FDA Link
06/2022 - 12/2008
4AlbuminsIBA
05/2018 - 11/2011
4CollagenIBA
10/2016 - 05/2004
4Streptozocin (Streptozotocin)FDA Link
05/2008 - 05/2003
3ChemokinesIBA
12/2023 - 08/2012
3CytokinesIBA
04/2023 - 01/2015
3Lipoproteins (Lipoprotein)IBA
08/2022 - 09/2021
3Vitamin DFDA LinkGeneric
10/2021 - 08/2015
3HDL LipoproteinsIBA
02/2021 - 01/2012
3Fenofibrate (CiL)FDA LinkGeneric
06/2018 - 01/2016
3Cholesterol Ester Transfer ProteinsIBA
01/2017 - 12/2008
3Advanced Glycation End ProductsIBA
01/2011 - 04/2004
3propagermanium (Ge 132)IBA
03/2010 - 09/2007
3Messenger RNA (mRNA)IBA
03/2010 - 08/2004
3Apolipoproteins E (ApoE)IBA
06/2009 - 09/2004
3Warfarin (Coumadin)FDA LinkGeneric
01/2008 - 05/2003
2ORALIT (ORS)IBA
10/2023 - 10/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2023 - 09/2007
2anamorelinIBA
01/2023 - 01/2021
2ApolipoproteinsIBA
08/2022 - 07/2007
2omega-Chloroacetophenone (Mace)IBA
12/2021 - 01/2017
2hydroxide ionIBA
10/2021 - 08/2015
2AntioxidantsIBA
02/2021 - 12/2008

Therapy/Procedure

17Therapeutics
10/2023 - 09/2007
9Long-Term Care
05/2023 - 07/2013
8Activities of Daily Living (ADL)
11/2023 - 08/2017
5Palliative Care (Palliative Therapy)
11/2022 - 06/2017
5Drug Therapy (Chemotherapy)
08/2021 - 01/2016
5Polypharmacy
08/2021 - 05/2004
3Resistance Training
04/2023 - 07/2017
3Secondary Prevention
02/2021 - 06/2016
2Cognitive Training
01/2024 - 03/2016
2Terminal Care (Care, Terminal)
09/2021 - 01/2016